Avandia Allergic Reactions – Side Effects of Avandia
An allergic reaction is the body's way of responding to a foreign substance. When the immune system is triggered in an attempt to protect the body, a hypersensitivity reaction (allergic reaction) occurs. According to the Allergy Foundation of America (AAFA), approximately 17 million individuals visit a physician due to allergic reactions each year. In rare cases, an allergic reaction can be life-threatening.
Although allergic reactions occur for various reasons, many are a result of a chemical substance in the body, including medication. Avandia, a type 2 diabetes drug, is known to cause allergic reactions in some individuals.
Symptoms of Avandia Allergies
If you recognize the following symptoms and are taking Avandia treatment, please consult your physician immediately:
- Skin rash
- Hives
- Itching
- Wheezing/trouble breathing
- Unexplained swelling
While there has been no official Avandia FDA warnings, it is important to note that this drug has been linked to serious medical conditions. If you are currently on Avandia and are experiencing symptoms of an allergic reaction, it is essential that you seek medical advice right away.
Avandia Legal Advice
In addition to allergic reactions and other Avandia side effects, the drug is associated with serious complications, including vision loss, heart failure, stroke and liver poisoning. An Avandia lawyer from Viles & Beckman can help you file a personal injury or wrongful death lawsuit against the manufacturer for any health problems, especially if you are an Avandia heart attack victim. The distinguished personal injury attorneys at Viles & Beckman have years of training and experience handling defective drug cases, including Avandia cases.
Our legal team will represent you aggressively in the pursuit of justice and monetary compensation that you and your loved ones deserve for your pain and distress. Please call Viles & Beckman at 1-800-689-1094 to learn more about your legal rights as a defective drug victim.
Page Updated March 17, 2010
